Isolated ventricular non-compaction: an underdiagnosed cause of congestive heart failure

Shmuel Schwartzenberg1, Jack Sherez, Dov Wexler

  • 1Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. sschwartzenberg@gmail.com

Insights

Isolated ventricular non-compaction, a rare congenital cardiomyopathy, is often underdiagnosed. Early diagnosis is crucial for asymptomatic patients, family screening, and guiding treatments like anticoagulation and cardioverter defibrillators.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Isolated ventricular non-compaction is a rare congenital cardiomyopathy.
  • It is frequently underdiagnosed, particularly in asymptomatic individuals.
  • Diagnosis is vital for risk stratification and management.

Purpose of the Study:

  • To present the clinical and imaging characteristics of isolated ventricular non-compaction.
  • To discuss therapeutic dilemmas in managing patients with this condition.
  • To highlight the importance of early diagnosis and screening.

Main Methods:

  • Review of clinical case data.
  • Analysis of imaging findings (e.g., echocardiography, cardiac MRI).
  • Discussion of current treatment guidelines and therapeutic options.

Main Results:

  • Detailed description of typical clinical presentations.
  • Identification of key imaging features for diagnosis.
  • Exploration of challenges in therapeutic decision-making.

Conclusions:

  • Isolated ventricular non-compaction requires increased clinical awareness for timely diagnosis.
  • Screening of relatives is essential for early detection and management.
  • Therapeutic strategies should be individualized based on patient characteristics and risk factors.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...